Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. The metabolism of NR is unique from that of other more commonly known forms of vitamin B3, nicotinamide and nicotinic acid. Specifically, NR has been shown in a pre-clinical study to be the most effective form of vitamin B3  at increasing nicotinamide adenine dinucleotide (NAD+)2.
Market Analysis and Insights: Global Nicotinamide Ribose (NR) Market
Due to the COVID-19 pandemic, the global Nicotinamide Ribose (NR) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Pharmaceutical Grade accounting for % of the Nicotinamide Ribose (NR) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Dietary Supplement segment is altered to an % CAGR throughout this forecast period.
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. The metabolism of NR is unique from that of other more commonly known forms of vitamin B3, nicotinamide and nicotinic acid. Specifically, NR has been shown in a pre-clinical study to be the most effective form of vitamin B3  at increasing nicotinamide adenine dinucleotide (NAD+)2.
Global Nicotinamide Ribose (NR) Scope and Segment
Nicotinamide Ribose (NR) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Nicotinamide Ribose (NR) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Pharmaceutical Grade
Food Grade
Other
Segment by Application
Dietary Supplement
Pharmaceutical Industry
Other
By Company
Chroma Dex
Elysium Health
Tru Niagen
Thorne
Zhejiang Jiahua Pharmchemical
Shenzhen Longgesheng Technology
Bontac Bio-engineering
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE